Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder

被引:1
|
作者
Loi, Manuela [1 ]
Bastianini, Stefano [1 ]
Candini, Giulia [1 ]
Rizzardi, Nicola [2 ]
Medici, Giorgio [1 ]
Papa, Valentina [1 ]
Gennaccaro, Laura [1 ]
Mottolese, Nicola [1 ]
Tassinari, Marianna [1 ]
Uguagliati, Beatrice [1 ]
Berteotti, Chiara [1 ]
Martire, Viviana Lo [1 ]
Zoccoli, Giovanna [1 ]
Cenacchi, Giovanna [1 ]
Trazzi, Stefania [1 ]
Bergamini, Christian [2 ]
Ciani, Elisabetta [1 ]
机构
[1] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40126 Bologna, Italy
[2] Univ Bologna, Dept Pharm & Biotechnol, I-40126 Bologna, Italy
关键词
CDKL5 deficiency disorder; mouse model; prolonged QTc interval; heart aging; mitochondrial dysfunction; OXIDATIVE STRESS; AUTONOMIC DYSFUNCTION; SIGNALING PATHWAY; RETT-SYNDROME; SUDDEN-DEATH; KINASE; ACTIVATION; NEURONS; PROFILE; GROWTH;
D O I
10.3390/ijms24065552
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CDKL5 (cyclin-dependent kinase-like 5) deficiency disorder (CDD) is a severe neurodevelopmental disease that mostly affects girls, who are heterozygous for mutations in the X-linked CDKL5 gene. Mutations in the CDKL5 gene lead to a lack of CDKL5 protein expression or function and cause numerous clinical features, including early-onset seizures, marked hypotonia, autistic features, gastrointestinal problems, and severe neurodevelopmental impairment. Mouse models of CDD recapitulate several aspects of CDD symptomology, including cognitive impairments, motor deficits, and autistic-like features, and have been useful to dissect the role of CDKL5 in brain development and function. However, our current knowledge of the function of CDKL5 in other organs/tissues besides the brain is still quite limited, reducing the possibility of broad-spectrum interventions. Here, for the first time, we report the presence of cardiac function/structure alterations in heterozygous Cdkl5 +/- female mice. We found a prolonged QT interval (corrected for the heart rate, QTc) and increased heart rate in Cdkl5 +/- mice. These changes correlate with a marked decrease in parasympathetic activity to the heart and in the expression of the Scn5a and Hcn4 voltage-gated channels. Interestingly, Cdkl5 +/- hearts showed increased fibrosis, altered gap junction organization and connexin-43 expression, mitochondrial dysfunction, and increased ROS production. Together, these findings not only contribute to our understanding of the role of CDKL5 in heart structure/function but also document a novel preclinical phenotype for future therapeutic investigation.
引用
收藏
页数:26
相关论文
共 50 条
  • [41] Gut microbiota profile in CDKL5 deficiency disorder patients
    Borghi, Elisa
    Xynomilakis, Ornella
    Ottaviano, Emerenziana
    Ceccarani, Camilla
    Vigano, Ilaria
    Tognini, Paola
    Vignoli, Aglaia
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [42] Effect of ganaxolone on behaviors in children with the CDKL5 Deficiency Disorder
    Downs, J.
    Aimetti, A.
    Busse, G.
    Jacoby, P.
    ANNALS OF NEUROLOGY, 2022, 92 : S89 - S90
  • [43] Electrophysiological biomarkers of brain function in CDKL5 deficiency disorder
    Saby, Joni N.
    Mulcahey, Patrick J.
    Zavez, Alexis E.
    Peters, Sarika U.
    Standridge, Shannon M.
    Swanson, Lindsay C.
    Lieberman, David N.
    Olson, Heather E.
    Key, Alexandra P.
    Percy, Alan K.
    Neul, Jeffrey L.
    Nelson, Charles A.
    Roberts, Timothy P. L.
    Benke, Timothy A.
    Marsh, Eric D.
    BRAIN COMMUNICATIONS, 2022, 4 (04)
  • [44] Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorder
    Tassinari, Marianna
    Uguagliati, Beatrice
    Trazzi, Stefania
    Cerchier, Camilla Bruna
    Cavina, Ottavia Vera
    Mottolese, Nicola
    Loi, Manuela
    Candini, Giulia
    Medici, Giorgio
    Ciani, Elisabetta
    NEUROBIOLOGY OF DISEASE, 2023, 182
  • [45] Ganaxolone for management of seizures associated with CDKL5 deficiency disorder
    Yasmen, Nelufar
    Sluter, Madison N.
    Yu, Ying
    Jiang, Jianxiong
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2023, 44 (02) : 128 - 129
  • [46] Influences on the trajectory and subsequent outcomes in CDKL5 deficiency disorder
    Leonard, Helen
    Junaid, Mohammed
    Wong, Kingsley
    Aimetti, Alex A.
    Knight, Elia Pestana
    Downs, Jenny
    EPILEPSIA, 2022, 63 (02) : 352 - 363
  • [47] CDKL5 Deficiency Disorder-A Complex Epileptic Encephalopathy
    Jakimiec, Martyna
    Paprocka, Justyna
    Smigiel, Robert
    BRAIN SCIENCES, 2020, 10 (02)
  • [48] CDKL5 Deficiency Disorder (CDD)-Rare Presentation in Male
    Rodak, Malgorzata
    Jonderko, Mariola
    Rozwadowska, Patrycja
    Machnikowska-Sokolowska, Magdalena
    Paprocka, Justyna
    CHILDREN-BASEL, 2022, 9 (12):
  • [49] Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder
    Devinsky, Orrin
    King, LaToya
    Schwartz, Danielle
    Conway, Erin
    Price, Dana
    EPILEPSIA, 2021, 62 (07) : E98 - E102
  • [50] Phenotypic characterization of Cdkl5-knockdown neurons establishes elongated cilia as a functional assay for CDKL5 Deficiency Disorder
    Di Nardo, Alessia
    Ruhmkorf, Alina
    Award, Patricia
    Brennecke, Ashton
    Fagiolini, Michela
    Sahin, Mustafa
    NEUROSCIENCE RESEARCH, 2022, 176 : 73 - 78